Image: © anusorn nakdee | iStock
A scientific review published in Genes & Diseases highlights how PIWI proteins and PIWI-interacting RNAs (piRNAs) regulate stem cell function, offering new epigenetic targets to enhance tissue repair and disease treatments
Epigenetic regulation and genome protection
The success of stem cell therapies relies on precise control over gene activity. PIWI/piRNA complexes function as master regulators of this process through epigenetic mechanisms, switching specific genes on or off without altering the underlying DNA sequence.
Primary functions in stem cell maintenance include:
Genome safeguarding:
They silence transposable genetic elements (“jumping genes”), preventing DNA instability and maintaining cellular integrity.
Chromatin and methylation control:
The complexes coordinate chromatin remodelling and DNA methylation to preserve a stem cell’s self-renewal capacity.
Guided differentiation:
They regulate the exact pathways required for stem cells to mature into specialised cell types for tissue repair.
Expanding scope in somatic tissues and pathology
While historically studied in reproductive biology, researchers have identified active PIWI/piRNA pathways across diverse somatic cell types. Their presence in adult tissues opens new avenues for therapeutic intervention:
Cancer biology:
Dysregulated PIWI/piRNA activity fuels cancer stem cell survival, driving treatment resistance and tumour progression.
Bone regeneration:
Specific piRNAs influence osteoblast function and bone formation, presenting targets to counteract bone loss and structural degradation.
Neurodegeneration and ageing:
Emerging evidence ties piRNA pathways to neural stem cell maintenance and healthy tissue longevity.
Image Caption: A roadmap for understanding Table 1. Image link: https://ars.els-cdn.com/content/image/1-s2.0-S2352304225003435-gr1_lrg.jpg. Credit Genes & Diseases
Clinical translation challenges and future tools
Before PIWI/piRNA mechanisms can be integrated into routine clinical practice, several technical hurdles must be resolved:
Targeting precision:
Developing delivery systems that hit specific cell populations without off-target effects.
Molecular stability:
Improving the functional lifespan of engineered RNA constructs inside the body.
Safety protocols:
Ensuring long-term genomic stability and preventing unintended epigenetic modifications.
To bridge these gaps, researchers are pairing gene delivery platforms and biomaterials with artificial intelligence for target discovery and molecular engineering.
Editor’s Recommended Articles